메뉴 건너뛰기




Volumn 22, Issue 6, 2010, Pages 284-292

The balance between anti-ischemic efficacy and bleeding risk of antithrombotic therapy in percutaneous coronary intervention: A Yin-Yang paradigm

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; PRASUGREL; RAPAMYCIN; RETEPLASE; TICAGRELOR; TICLOPIDINE; WARFARIN;

EID: 77953147391     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (14)

References (56)
  • 1
    • 0024406369 scopus 로고
    • Steering committee of the physicians' health study research group. Final report on the aspirin component of the ongoing physicians' health study
    • Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
    • (1989) N. Engl. J. Med. , vol.321 , pp. 129-135
  • 2
    • 0026042937 scopus 로고
    • Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research group on instability in coronary artery disease in southeast sweden
    • Wallentin LC. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden. J Am Coll Cardiol 1991;18:1587-1593.
    • (1991) J. Am. Coll. Cardiol. , vol.18 , pp. 1587-1593
    • Wallentin, L.C.1
  • 3
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
    • (2002) Br. Med. J. , vol.324 , pp. 71-86
  • 4
    • 77953143481 scopus 로고    scopus 로고
    • The AAA investigators. Aspirin for asymptomatic atherosclerosis
    • Presented at, August
    • The AAA Investigators. Aspirin for Asymptomatic Atherosclerosis. Presented at the European Society of Cardiology Annual Scientific Sessions, August 2009.
    • (2009) The European Society of Cardiology Annual Scientific Sessions
  • 5
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 6
    • 65249184387 scopus 로고    scopus 로고
    • Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: Insights from the PCI-CURE study
    • Jolly SS, Pogue J, Haladyn K, et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: Insights from the PCI-CURE study. Eur Heart J 2009;30:900-907.
    • (2009) Eur. Heart J. , vol.30 , pp. 900-907
    • Jolly, S.S.1    Pogue, J.2    Haladyn, K.3
  • 7
    • 77953167703 scopus 로고    scopus 로고
    • CURRENT OASIS 7 investigators. Clopidogrel optimal loading dose Usage to reduce recurrent EveNTs - Organization to assess strategies in ischemic syndromes
    • Presented at, August
    • CURRENT OASIS 7 Investigators. Clopidogrel optimal loading dose Usage to Reduce Recurrent EveNTs - Organization to Assess Strategies in Ischemic Syndromes. Presented at the European Society of Cardioly Annual Scientific Sessions, August 2009.
    • (2009) The European Society of Cardioly Annual Scientific Sessions
  • 8
    • 38049169354 scopus 로고    scopus 로고
    • 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A Report of the American college of cardiology/American heart association task force on practice guidelines
    • King SB, Smith SC, Hirshfeld JW, et al. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:172-209.
    • (2008) Circulation , vol.117 , pp. 172-209
    • King, S.B.1    Smith, S.C.2    Hirshfeld, J.W.3
  • 9
    • 0032481092 scopus 로고    scopus 로고
    • A clinical trial comparing three antithromboticdrug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators
    • Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithromboticdrug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-1671.
    • (1998) N. Engl. J. Med. , vol.339 , pp. 1665-1671
    • Leon, M.B.1    Baim, D.S.2    Popma, J.J.3
  • 10
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-533.
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 11
    • 65249184387 scopus 로고    scopus 로고
    • Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: Insights from the PCI-CURE study
    • Jolly SS, Pogue J, Haladyn K, et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: Insights from the PCI-CURE study. Eur Heart J 2009;30:900-907.
    • (2009) Eur. Heart J. , vol.30 , pp. 900-907
    • Jolly, S.S.1    Pogue, J.2    Haladyn, K.3
  • 12
    • 0034622539 scopus 로고    scopus 로고
    • Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS)
    • Bertrand M, Rupprecht H, Urban P, et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000;102:624-629.
    • (2000) Circulation , vol.102 , pp. 624-629
    • Bertrand, M.1    Rupprecht, H.2    Urban, P.3
  • 13
    • 0343750695 scopus 로고    scopus 로고
    • A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
    • Muller C, Buttner H, Petersen J, et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590-593.
    • (2000) Circulation , vol.101 , pp. 590-593
    • Muller, C.1    Buttner, H.2    Petersen, J.3
  • 14
    • 4644295940 scopus 로고    scopus 로고
    • Antithrombotic therapy during percutaneous coronary intervention: The seventh ACCP conference on antithrombotic and thrombolytic therapy
    • Popma JJ, Berger P, Ohman EM, et al. Antithrombotic therapy during percutaneous coronary intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl): 576S-599S.
    • (2004) Chest , vol.126 , Issue.3 SUPPL.
    • Popma, J.J.1    Berger, P.2    Ohman, E.M.3
  • 15
    • 73449142798 scopus 로고    scopus 로고
    • American college of cardiology foundation/American heart association task force on practice guidelines. 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update)
    • A report of the American college of cardiology foundation/American heart association task force on practice guidelines
    • Kushner FG, Hand M, Smith SC Jr, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-2306.
    • (2009) Circulation , vol.120 , pp. 2271-2306
    • Kushner, F.G.1    Hand, M.2    Smith Jr., S.C.3
  • 16
    • 0035908781 scopus 로고    scopus 로고
    • The CURE investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
    • Mehta SR, Yusuf S, Peters RJ, et al; the CURE Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001;358:527-533.
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.3
  • 17
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
    • Steinhubl S, Berger P, Mann J, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002;288:2411-2420.
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.1    Berger, P.2    Mann, J.3
  • 18
    • 58749093909 scopus 로고    scopus 로고
    • CREDO investigators. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the clopidogrel for the reduction of events during observation (CREDO) trial
    • Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ; CREDO Investigators. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J 2009;157:369-374.
    • (2009) Am. Heart J. , vol.157 , pp. 369-374
    • Aronow, H.D.1    Steinhubl, S.R.2    Brennan, D.M.3    Berger, P.B.4    Topol, E.J.5
  • 19
    • 36849082648 scopus 로고    scopus 로고
    • TIMI study group. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: A clopidogrel as adjunctive reperfusion therapy-thrombolysis in myocardial infarction (CLARITY-TIMI) 28 study
    • Gibson CM, Murphy SA, Pride YB, et al; TIMI Study Group. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: A Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Am Heart J 2008;155:133-139.
    • (2008) Am. Heart J. , vol.155 , pp. 133-139
    • Gibson, C.M.1    Murphy, S.A.2    Pride, Y.B.3
  • 20
    • 36148983750 scopus 로고    scopus 로고
    • TRITON-TIMI 38 investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015.
    • (2007) N. Engl. J. Med. , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1    Braunwald, E.2    McCabe, C.H.3
  • 21
    • 42149119040 scopus 로고    scopus 로고
    • TRITON-TIMI 38 investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: A subanalysis of a randomised trial
    • Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: A subanalysis of a randomised trial. Lancet 2008;371:1353-1363.
    • (2008) Lancet , vol.371 , pp. 1353-1363
    • Wiviott, S.D.1    Braunwald, E.2    McCabe, C.H.3
  • 22
    • 43749117048 scopus 로고    scopus 로고
    • Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction) analysis
    • Antman EM, Wiviott SD, Murphy SA, et al. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel- Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol 2008;51:2028-2033.
    • (2008) J. Am. Coll. Cardiol. , vol.51 , pp. 2028-2033
    • Antman, E.M.1    Wiviott, S.D.2    Murphy, S.A.3
  • 23
    • 70149101223 scopus 로고    scopus 로고
    • The PLATO investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • Wallentin L, Becker RC, Budaj A, et al; the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057.
    • (2009) N. Engl. J. Med. , vol.361 , pp. 1045-1057
    • Wallentin, L.1    Becker, R.C.2    Budaj, A.3
  • 24
    • 33645507439 scopus 로고    scopus 로고
    • Intracoronary stenting and antithrombotic: Regimen rapid early action for coronary treatment 2 (ISAR-REACT 2) trial investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR-REACT 2 randomized trial
    • Kastrati A, Mehilli J, Neumann FJ, et al; Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR-REACT 2 randomized trial. JAMA 2006;295:1531-1538.
    • (2006) JAMA , vol.295 , pp. 1531-1538
    • Kastrati, A.1    Mehilli, J.2    Neumann, F.J.3
  • 25
    • 65549139808 scopus 로고    scopus 로고
    • Bavarian reperfusion alternatives evaluation-3 (BRAVE-3) study investigators. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: A randomized double-blind trial
    • Mehilli J, Kastrati A, Schulz S, et al; Bavarian Reperfusion Alternatives Evaluation-3 (BRAVE-3) Study Investigators. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: A randomized double-blind trial. Circulation 2009;119:1933-1940.
    • (2009) Circulation , vol.119 , pp. 1933-1940
    • Mehilli, J.1    Kastrati, A.2    Schulz, S.3
  • 26
    • 33846987535 scopus 로고    scopus 로고
    • ACUITY investigators. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: The ACUITY Timing trial
    • Stone GW, Bertrand ME, Moses JW, et al; ACUITY Investigators. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA 2007;297:591-602.
    • (2007) JAMA , vol.297 , pp. 591-602
    • Stone, G.W.1    Bertrand, M.E.2    Moses, J.W.3
  • 27
    • 66149124479 scopus 로고    scopus 로고
    • EARLY ACS investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes
    • Giugliano RP, White JA, Bode C, et al; EARLY ACS Investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009;360:2176-2190.
    • (2009) N. Engl. J. Med. , vol.360 , pp. 2176-2190
    • Giugliano, R.P.1    White, J.A.2    Bode, C.3
  • 28
    • 2242477091 scopus 로고    scopus 로고
    • The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
    • The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 2007;330:956-961.
    • (2007) N. Engl. J. Med. , vol.330 , pp. 956-961
  • 29
    • 33750300540 scopus 로고    scopus 로고
    • Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the prevention of ischemic complications (EPIC) trial
    • Marmur JD, Mitre CA, Barnathan E, Cavusoglu E. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am Heart J 2006;152:876-881.
    • (2006) Am. Heart J. , vol.152 , pp. 876-881
    • Marmur, J.D.1    Mitre, C.A.2    Barnathan, E.3    Cavusoglu, E.4
  • 30
    • 45649083470 scopus 로고    scopus 로고
    • One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized early discharge after transradial stenting of coronary arteries (EASY) study
    • Bertrand OF, Rodés-Cabau J, Larose E, et al. One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of coronary Arteries (EASY) Study. Am Heart J 2008;156:135-140.
    • (2008) Am. Heart J. , vol.156 , pp. 135-140
    • Bertrand, O.F.1    Rodés-Cabau, J.2    Larose, E.3
  • 31
    • 60949098494 scopus 로고    scopus 로고
    • Abbreviated infusion of eptifibatide after successful coronary intervention. The BRIEF-PCI (brief infusion of eptifibatide following percutaneous coronary intervention) randomized trial
    • Fung AY, Saw J, Starovoytov A, et al. Abbreviated infusion of eptifibatide after successful coronary intervention. The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. J Am Coll Cardiol 2009;53:837-845.
    • (2009) J. Am. Coll. Cardiol. , vol.53 , pp. 837-845
    • Fung, A.Y.1    Saw, J.2    Starovoytov, A.3
  • 32
    • 0034332695 scopus 로고    scopus 로고
    • Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) Trial
    • Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 2000;36:1489-1496.
    • (2000) J. Am. Coll. Cardiol. , vol.36 , pp. 1489-1496
    • Herrmann, H.C.1    Moliterno, D.J.2    Ohman, E.M.3
  • 33
    • 44249120546 scopus 로고    scopus 로고
    • FINESSE investigators. Facilitated PCI in patients with ST-elevation myocardial infarction
    • Ellis SG, Tendera M, de Belder MA, et al; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-2217.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 2205-2217
    • Ellis, S.G.1    Tendera, M.2    De Belder, M.A.3
  • 34
    • 0028082271 scopus 로고
    • Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic therapy in acute coronary syndromes research group
    • Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation 1994;89:81-88.
    • (1994) Circulation , vol.89 , pp. 81-88
    • Cohen, M.1    Adams, P.C.2    Parry, G.3
  • 35
    • 0029771618 scopus 로고    scopus 로고
    • Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis
    • Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 1996;276:811-815.
    • (1996) JAMA , vol.276 , pp. 811-815
    • Oler, A.1    Whooley, M.A.2    Oler, J.3    Grady, D.4
  • 36
    • 34548634592 scopus 로고    scopus 로고
    • Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial)
    • Valencia R, Price MJ, Sawhney N, et al. Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial). Am J Cardiol 2007;100:1099-1102.
    • (2007) Am. J. Cardiol. , vol.100 , pp. 1099-1102
    • Valencia, R.1    Price, M.J.2    Sawhney, N.3
  • 37
    • 0033861184 scopus 로고    scopus 로고
    • Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the ESSENCE study. Efficacy and Safety of Subcutaneous enoxaparin in non-Q wave coronary events
    • Goodman SG, Cohen M, Bigonzi F, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. J Am Coll Cardiol 2000;36:693-698.
    • (2000) J. Am. Coll. Cardiol. , vol.36 , pp. 693-698
    • Goodman, S.G.1    Cohen, M.2    Bigonzi, F.3
  • 38
    • 33845323043 scopus 로고    scopus 로고
    • Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the superior yield of the new strategy of enoxaparin, revascularization and glycoprotein IIb/IIIa inhibitors (SYNERGY) trial
    • White HD, Kleiman NS, Mahaffey KW, et al. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. Am Heart J 2006;152:1042-1050.
    • (2006) Am. Heart J. , vol.152 , pp. 1042-1050
    • White, H.D.1    Kleiman, N.S.2    Mahaffey, K.W.3
  • 39
    • 33748431522 scopus 로고    scopus 로고
    • STEEPLE investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
    • Montalescot G, White HD, Gallo R, et al; STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 2006;355:1006-1017.
    • (2006) N. Engl. J. Med. , vol.355 , pp. 1006-1017
    • Montalescot, G.1    White, H.D.2    Gallo, R.3
  • 40
    • 37148999983 scopus 로고    scopus 로고
    • Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: Quantitative review of randomized trials
    • Dumaine R, Borentain M, Bertel O, et al. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: Quantitative review of randomized trials. Arch Intern Med 2007;167:2423-2430.
    • (2007) Arch. Intern. Med. , vol.167 , pp. 2423-2430
    • Dumaine, R.1    Borentain, M.2    Bertel, O.3
  • 41
    • 0037453968 scopus 로고    scopus 로고
    • REPLACE-2 investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial
    • Lincoff AM, Bittl JA, Harrington RA, et al; REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863.
    • (2003) JAMA , vol.289 , pp. 853-863
    • Lincoff, A.M.1    Bittl, J.A.2    Harrington, R.A.3
  • 42
    • 44249122195 scopus 로고    scopus 로고
    • Bivalirudin during primary PCI in acute myocardial infarction
    • Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-2230.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 2218-2230
    • Stone, G.W.1    Witzenbichler, B.2    Guagliumi, G.3
  • 43
    • 50249086970 scopus 로고    scopus 로고
    • Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (acute catheterization and urgent intervention triage strategy) trial
    • White HD, Ohman EM, Lincoff AM, et al. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2008;52:807-814.
    • (2008) J. Am. Coll. Cardiol. , vol.52 , pp. 807-814
    • White, H.D.1    Ohman, E.M.2    Lincoff, A.M.3
  • 44
    • 20144373165 scopus 로고    scopus 로고
    • ASPIRE investigators. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra study in percutaneous coronary intervention: A randomized evaluation (ASPIRE) pilot trial
    • Mehta SR, Steg PG, Granger CB, et al; ASPIRE Investigators. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial. Circulation 2005;111:1390-1397.
    • (2005) Circulation , vol.111 , pp. 1390-1397
    • Mehta, S.R.1    Steg, P.G.2    Granger, C.B.3
  • 45
    • 35348987492 scopus 로고    scopus 로고
    • Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
    • Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial. J Am Coll Cardiol 2007;50:1742-1751.
    • (2007) J. Am. Coll. Cardiol. , vol.50 , pp. 1742-1751
    • Mehta, S.R.1    Granger, C.B.2    Eikelboom, J.W.3
  • 46
    • 0032542028 scopus 로고    scopus 로고
    • Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
    • Urban P, Macaya C, Rupprecht HJ, et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998;98:2126-2132.
    • (1998) Circulation , vol.98 , pp. 2126-2132
    • Urban, P.1    Macaya, C.2    Rupprecht, H.J.3
  • 47
    • 64049096437 scopus 로고    scopus 로고
    • Predictors of coronary stent thrombosis: The dutch stent thrombosis registry
    • van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: The Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53:1399-1409.
    • (2009) J. Am. Coll. Cardiol. , vol.53 , pp. 1399-1409
    • Van Werkum, J.W.1    Heestermans, A.A.2    Zomer, A.C.3
  • 48
    • 45649085740 scopus 로고    scopus 로고
    • Correlates of late and very late thrombosis of drug eluting stents
    • Mishkel GJ, Moore AL, Markwell S, Shelton ME. Correlates of late and very late thrombosis of drug eluting stents. Am Heart J 2008;156:141-147.
    • (2008) Am. Heart J. , vol.156 , pp. 141-147
    • Mishkel, G.J.1    Moore, A.L.2    Markwell, S.3    Shelton, M.E.4
  • 49
    • 38949197815 scopus 로고    scopus 로고
    • Thrombus aspiration during primary percutaneous coronary intervention
    • Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 557-567
    • Svilaas, T.1    Vlaar, P.J.2    Van Der Horst, I.C.3
  • 50
    • 33745129383 scopus 로고    scopus 로고
    • Devices for distal protection during percutaneous coronary revascularization
    • Mauri L, Rogers C, Baim, DS. Devices for distal protection during percutaneous coronary revascularization. Circulation 2006;113:2651-2656.
    • (2006) Circulation , vol.113 , pp. 2651-2656
    • Mauri, L.1    Rogers, C.2    Baim, D.S.3
  • 51
    • 62849107586 scopus 로고    scopus 로고
    • Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications
    • Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009;10:88-93.
    • (2009) Cardiovasc. Revasc Med. , vol.10 , pp. 88-93
    • Fuchs, S.1    Kornowski, R.2    Teplitsky, I.3
  • 52
    • 68949092641 scopus 로고    scopus 로고
    • Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction
    • Manoukian SV. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol 2009;104(5 Suppl): 9C-15C.
    • (2009) Am. J. Cardiol. , vol.104 , Issue.5 SUPPL.
    • Manoukian, S.V.1
  • 53
    • 33845978383 scopus 로고    scopus 로고
    • Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal
    • Cantor WJ, Mahaffey KW, Huang Z, et al. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Cath Cardiovasc Interv 2006;69:73-83.
    • (2006) Cath Cardiovasc. Interv. , vol.69 , pp. 73-83
    • Cantor, W.J.1    Mahaffey, K.W.2    Huang, Z.3
  • 54
    • 70350520487 scopus 로고    scopus 로고
    • Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GP IIb/IIIa inhibitors for acute coronary syndromes
    • De Carlo M, Borelli G, Gistri R, et al. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GP IIb/IIIa inhibitors for acute coronary syndromes. Catheter Cardiovasc Interv 2009;74:408-415.
    • (2009) Catheter Cardiovasc. Interv. , vol.74 , pp. 408-415
    • De Carlo, M.1    Borelli, G.2    Gistri, R.3
  • 55
    • 0035927970 scopus 로고    scopus 로고
    • TACTICS-TIMI 18 investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
    • Cannon CP, Weintraub WS, Demopoulos LA, et al; TACTICS-TIMI 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887.
    • (2001) N. Engl. J. Med. , vol.344 , pp. 1879-1887
    • Cannon, C.P.1    Weintraub, W.S.2    Demopoulos, L.A.3
  • 56
    • 2442443079 scopus 로고    scopus 로고
    • A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention
    • Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol 2004;16:243-246.
    • (2004) J. Invasive Cardiol. , vol.16 , pp. 243-246
    • Vaitkus, P.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.